8 children with different petit mal epilepsies were systematically treated with ACTH and dexamethasone. CCT examinations were performed before, during and after treatment. In all children severe cerebral changes. enlargement of ventricles and subarachnoid space developed during the initial phase of treatment with Depot-ACTH. Similar changes, but to a less severe degree, could be demonstrated during the phase of dexamethasone therapy thereafter. In all patients cerebral changes disappeared after hormonal treatment had ended. At this point many children had a developmental spurt, developmental relapses could not be observed. It is suggested that these reversible changes seen on CCT scans represent a form of morphological plasticity of brain structures. These results bear certain consequences as to the therapy of cerebral edema.
Referring to the article of Pente/la et al in this issue of Neuropediatrics we report on experiences with ACTH therapy in infantile spasms. In addition we want to point out the reasons which led us to use ACTH fragments for therapeutic trials in children with infantile spasms.Adrenocorticotropic hormone (ACTH) has been a useful drug in the treatment of petit mal since 1950 (Klein and Livingstone 1950). The compound was successfully used in its natural form with 39 amino acids (ACTHI-39) and in its fragmented form with 24 amino acids (ACTHI-24), the latter being the most common and most frequently applied form of ACTH. We recently completed a prospective study on infan.. tile spasms and Lennox syndrome (Lagenstein et al 1978a, b) in which we administered an ACTH-fragment consisting of 23 amino acids (ACTHI-23). All the ACTH molecules mentioned caused marked hypercortisolaemia which was not sig.. nificantly different when induced by ACTHI-23 (Willig et al 1978). As a result maximal stimulated adrenals led to severe side efTects -these are familiar from Cushing's disease.Conventional ACTHI-24 was very efTective upon infantile spasms (Singer et al 1980). Particularly in infantile spasms beginning within the first year of life, and in centrencephalic myoclonic-astatic petit mal cases of older children ACTH seems to be a suitable drug and also seems to be most effective if it is applied within the first month of the spasm onset as far as infantile spasms are concemed.In spite of good seizure control with ACTH, physicians he.. sitate to administer corticotropins because the side effects may appear even more impressive than the seizures them.. selves when treatment is carried out for aperiod of 3 to 6 months at an ACTH dose of80 IV per day.After one of our patients on ACTH therapy had died from pneumonia, we strongly considered how the side effects could be reduced withoutjeopardizing the positive effects ofACTH. Our own observations during the hormonal seizure treatment led us to the conclusion that the therapeutical aministration ofACTH has a direct effect on the central nervous system and not via the adrenocortical hormones: a) Dose-dependency in relation to the effect of ACTH From the tenth treatment day on ACTH led to a maximal cortisol level of 100 J.1g/dl on average with large individual fluctuations. The moment of therapy success was not con.. nected to the level of cortisol. One patient who showed the highest cortisol plasma level (440 Jlg/dl) did not react to the ACTH therapy. This was an indication that ACTH has a direct effect upon the brain and possibly does not have an effect via the adrenal cortex. The fact that only 15 IU ACTH is required in order to achieve a maximal adrenocortical effect also supports this theory. In addition, the results which have been reported in the literature clearly indicate that therapy success is dependent on the ACTH dose level. In our opinion these facts indicate that ACTH acts directly on the brain. b) Investigations of adrenocortical insufficiencyWe had the opportunity of...
Genetic counselling of the parents is prerequisite before prenatal diagnosis and prenatal therapy of CAH. Today, chorionic villous biopsy with DNA probe is the method of choice to identify homozygous CAH-fetuses. The aim of prenatal therapy is to prevent intrauterine virilization of the external genitalia in affected female fetuses. Therefore, dexamethasone (3 x 0.5 mg/d p.o.) is given to the mother immediately when pregnancy is confirmed, before prenatal diagnosis and karyotyping is possible. After the result of prenatal diagnosis, treatment is continued until term only when the fetus is affected and female. Prenatal diagnosis and effective treatment of female CAH fetuses greatly reduces the need for corrective surgery and thus helps to alleviate anxieties of prospective parents and therefore encourages further pregnancies. However, prenatal treatment of CAH to date still is an experimental therapy [corrected].
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.